Bandyopadhyay AS, Garon J, Seib K, Orenstein WA (2015). Polio vaccination: past, present and future. Future Microbiol. 10:791-808.
Crossref

Bodian D (1972). Poliomyelitis. In. Pathology of the Nervous System, Vol 3. Minckler (ed.). New York: McGraw-Hill, pp. 2323-2344.

Bodian D, Morgan I M, Howe HA (1949). Differentiation of types of poliomyelitis viruses. III. The grouping of fourteen strains into three basic immunological types. Am. J. Hyg. 49:234-245.

Brack M (1987). Agents Transmissible from Simians to Man. Berlin: Springer-Verlag.
Crossref

Centers for disease Control and prevention (CDC) (2006). Resurgence of wild poliovirus type 1 transmission and consequences of importation-21 countries, 2002–2005. MMWR 55:145-150.

Centers for disease Control and prevention (CDC) (2001a). Circulation of a type 2 vaccine-derived poliovirus-Egypt, 1982–1993. Morbid. Mortal. Weekly Rep. 50:41-51.

Centers for disease Control and prevention (CDC) (2001b). Progress toward global eradication of poliomyelitis. Morbid. Mortal. Weekly Rep. 2002a. 51:253-256.

Certification of poliomyelitis eradication- European Region (2002). MMWR -Morb. Mortal. Weekly. Rep. 51:572-574.

Cheuk DKL (2007). New Childhood Immunisation Programme in Hong Kong. The Hong Kong Medical Diary 12(7):22-24.

Dhole TN, Ayyagari A, Chowdhary R, Shakya AK, Shrivastav N, Datta T, Prakash V (2009). Non-Polio Enteroviruses in acute flaccid paralysis children of India: Vital assessment before Polio eradication. J. Paediatr. Child Health 45:409-413.
Crossref

Ertem M, Sarac A, Tumay S (2000). Poliomyelitis eradication programme: acute flaccid paralysis surveillance in Mardin and five other provinces around Mardin, Turkey 1998. Public Health 114:286-290.
Crossref

Faden H, Modlin JF, Thoms ML, McBean AM, Ferdon MB, Ogra PL (1990). Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J. Infect. Dis. 162(6):1291-1297.
Crossref

Fine EMP, Carneiro AM (1990). Transmissibility and persistence of oral polio vaccine viruses: Implications for the global poliomyelitis eradication initiative. Am. J. Epidemiol. 150:1011-1012.

Hovi T, Blomqvist S, Nasr E, Burns CC, Sarjakoski T, Ahmed N, Savolainen C, Roivainen M, Stenvik M, Laine P, Barakat I, Wahdan MH, Kamel FA, Asghar H, Pallansch MA, Kew OM, Gary HE Jr, de Gourville EM, El Bassioni L(2005). Environmental surveillance of wild poliovirus circulation in Egypt-balancing between Mugisha et al. Oral polio vaccination in captive chimpanzees detection sensitivity and workload. J. Virol. Methods 126:127-134.
Crossref

Hovi T, Shulman LM, Vander Avoort H, Deshpande J, Ro Iva Inen M, De Gourville EM (2011). REVIEW ARTICLE Role of environmental poliovirus surveillance in global polio eradication and beyond. Epidemiol. Infect. Page 1 of 13. f Cambridge University Press and World Health Organization.

Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, Pallansch M (2004) . Circulating vaccinederived polioviruses: current state of knowledge. Bull. World Health Organ. 82:16-32.

Lopez-Medina E, Melgar M, Gaensbauer JT, Bandyopadhyay AS, Borate BR, Weldon WC, Rüttimann R, Ward J, Clemens R, Asturias EJ (2017). Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America. Vaccine 35(28):3591-3597.
Crossref

Moriniere BJ, van Loon FP, Rhodes PH, Klein-Zabban ML, Frank-Senat B, Herrington JE, Patriarca PA (1993). Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet 341:1545-1550.
Crossref

Mugisha L, Pauli G, Opuda-Asibo J, Joseph OO, Leendertz FH, Diedrich S (2010). Evaluation of poliovirus antibody titers in orally vaccinated semi-captive chimpanzees in Uganda. J. Med. Primatol. 39:123-128.
Crossref

Nathanson N, Martin JR (1979). The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemiology, and disappearance. Am. J. Epidemiol. 110:672-691.
Crossref

Patel M, Orenstein WA (2016). A World free of polio – the final steps. N. Engl. J. Med. 374:501-503.
Crossref

Patriarca PA, Wright PF, John TJ (1991). Factors affecting immunogenicity of oral polio vaccine in developing countries: A review. Rev. Infect. Dis. 13:926-939.
Crossref

Pelczar MJ Jr, Chan ECS, Krieg NR (1993). Microbiology: Concepts and Applications. McGraw-Hill, Inc., New York. 698.

Platt LR, Estívariz CF, Sutter RW (2014). Vaccine-Associated Paralytic Poliomyelitis: A Review of the Epidemiology and Estimation of the Global Burden. Epidemiology and Global Burden of VAPP. J. Infect. Dis. 210(suppl_1):S380- S389.

Progress toward interruption of wild poliovirus transmission--Worldwide January 2005-March 2006 (2006). MMWR Morb. Mortal Wkly. Rep. 55(16):458-462.

Saleem AF, Mach O, Yousafzai MT, Khan A, Weldon WC, Oberste MS, Sutter RW, Zaidi AKM (2014). Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan. Vaccine 35(24):3209-3214.
Crossref

Tafuri S, Prato R, Martinelli D, Calvario A, Bozzi A, Labianca M, Patti A, Lopalco PL, Germinario C (2008). Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy). BMC Infect. Dis. 8(1):150.
Crossref

Tao Z, Zhang Y, Liu Y, Xu A, Lin X, Yoshida H, Xiong P, Zhu S, Wang S, Yan D, Song L,Wang H, Cui N, Xu W(2013). Isolation and Characterization of a Type 2 Vaccine-Derived Poliovirus from Environmental Surveillance in China, 2012. PloS One 8(12):e83975.
Crossref

Tao Z, Wang Z, Lin X, Wang S, Wang H, Yoshida H, Xu A, Song Y (2016). One-year Survey of human enteroviruses from sewage and the factors affecting virus adsorption to the suspended solids. Sci. Rep. 6:31474.
Crossref

The annual statistics book of health (2004). Ankara, Turkey: The Republic of Turkey Ministry of Health. P 68.

Thompson KM, Duintjer Tebbens RJ, Pallansch MA (2006). Evaluation of response scenarios to potential polio outbreaks using mathematical models. Risk Anal. 26:1541-1556.
Crossref

Vancelik S, Guraksin A, Ayyildiz A, and Beyhun N E (2007). Seroepidemiology of poliovirus antibody among the children in Eastern Turkey. Indian J. Med. Res. 126:528-533.

World Health Organization (WHO) (2004). Polio eradication initiative. Office of the Director-General and Department of Immunization, Vaccines and Biologicals, Family and Community Health. The Global Polio Eradication Initiative Strategic Plan 2004-2008. WHO: Geneva.

World Health Organization (WHO) (2013). Global Polio Eradication Initiative. Polio Eradication & Endgame Strategic Plan 2013-2018. Geneva, Switzerland: World Health Organization (2013).